Asia Pacific Advanced Wound Care Market Size, Share & Trends Analysis Report By Product (Moist, Antimicrobial), By Application (Chronic Wounds, Acute Wounds), By End-use, By Country, And Segment Forecasts, 2025 - 2030

Market Size & Trends

The Asia Pacific advanced wound care market size was estimated at USD 2.42 billion in 2024 and is projected to grow at a CAGR of 5.4% from 2025 to 2030. Major factors contributing to the market growth are the increasing demand for reducing hospital stays, the rising incidence of chronic wounds, and the rising number of surgeries in the region. The increasing incidence of chronic diseases such as diabetes, cancer, and other autoimmune diseases is anticipated to increase the incidence rate of chronic wounds in Asia Pacific.

Technological advancements in infection care, including advanced dressings and negative pressure wound therapy systems, enable healthcare providers to manage injuries outside traditional hospital settings effectively. For instance, in February 2023, 3M introduced its novel medical adhesive for use with a variety of sensors, long-term medical wearables, and health monitors. This adhesive can adhere to the skin for up to 28 days. This initiative was expected to expand the company’s product portfolio.

The increasing incidence of chronic injuries is a driving force propelling the growth of the Asia Pacific advanced wound care industry. With factors like aging populations, lifestyle changes, and the prevalence of chronic conditions such as diabetes and obesity on the rise in the region, there is a corresponding increase in the occurrence of chronic infections like diabetic foot ulcers and pressure ulcers. These infections often necessitate specialized and advanced wound care treatments to facilitate healing and prevent complications. For instance, In March 2024, the Albanese Government allocated over $3 million to support new initiatives aimed at addressing the often-overlooked epidemic of chronic wounds in Australia. Currently, an estimated 450,000 Australians are living with a chronic wound.

The rising number of surgeries across the region is one of the primary factors for propelling the growth of the Asia Pacific advanced wound care market. As healthcare infrastructure expands and access to surgical intervention improves, there is a parallel increase in post-operative injury management requirements. Surgical procedures, ranging from elective surgeries to complex interventions, often necessitate advanced wound management solutions to facilitate optimal healing and reduce the risk of complications.

This surge in surgical interventions, coupled with the rising prevalence of chronic diseases and age-related conditions, underscores the growing demand for advanced infection care products and therapies such as bioactive dressings, negative pressure wound therapy, and cellular and tissue-based treatments. For instance, according to the Janssen Asia Pacific, the region accounts for half of the globe's new cancer diagnoses, with a projected 36% rise in cancer-related deaths by 2030. The region boasts the highest occurrence rates of liver and stomach cancers worldwide, while prostate cancer has emerged as a prominent male cancer in select Asian nations.

Market Concentration & Characteristics

The market growth stage is medium, with an accelerating pace. This growth is fueled by a high degree of innovation, driven by technological advancements, rising demand for effective wound care solutions, and a strong emphasis on research and development to cater to the region's diverse healthcare needs.

The market growth stage is medium, with an accelerating pace. The market's high degree of innovation is driven by technological advancements, increasing demand for effective wound management solutions, and a growing focus on research and development to address the region's diverse healthcare needs. For instance, in October 2023, DuPont announced DuPont Liveo MG 7-9960, a novel silicone soft skin adhesive (SSA) tailored for advanced wound care and long-term medical device attachment, boasting enhanced adhesion and minimized cyclic properties, addressing the need for improved adhesion and patient comfort.

The Asia-Pacific advanced wound care market is also marked by numerous regulatory approvals, facilitating the introduction of new and innovative products. Regulatory bodies in the region are actively evaluating and authorizing advanced wound care solutions to ensure they meet safety and efficacy standards. This regulatory support accelerates the availability of advanced treatments, enhancing the market's growth and offering patients access to superior wound care options.

The Asia Pacific advanced wound care market is witnessing a surge in mergers and acquisitions (M&A) activities. Key players in the market are actively pursuing strategic acquisitions to expand their product portfolios, strengthen their market positions, and gain access to emerging technologies. These M&A deals are primarily focused on acquiring innovative wound care products, expanding distribution networks, and entering new markets.

Advanced wound care products offer specialized solutions for effective wound management; certain product substitutes can be considered in specific cases. These substitutes may include traditional wound care products like gauze dressings, ointments, and topical antimicrobial agents. However, it's important to note that these substitutes may not always provide the same level of efficacy and convenience as advanced wound care products, especially for complex or chronic wounds.

The Asia Pacific advanced wound care industry is characterized by a fragmented end user landscape, with a significant number of hospitals, clinics, and home healthcare providers. While a few large healthcare institutions dominate the market, a majority of the market share is held by a multitude of smaller healthcare facilities. This fragmented nature of the end user segment presents both opportunities and challenges for market players.

Product Insights

The moist segment led the market with the largest revenue share of 54.96% in 2024. The product is segmented into moist, antimicrobial, and active products. The moist segment is further segmented into foam dressings, Superabsorbent Dressings, film dressings, hydrocolloid dressings, alginate dressings, hydrogel dressings, collagen dressings, charcoal dressing, wound contact layers, greasy gauzes, and other advanced dressings. This high percentage can be attributed to an increasing geriatric population in many Asian countries, coupled with rising incidences of chronic diseases such as diabetes, which has led to a higher prevalence of chronic injuries that require advanced wound care solutions, including moist products.

The active segment is expected to grow at the fastest CAGR over the forecast period. The active segment is further segmented into biomaterials, skin-substitute, and growth factors. The advancements in healthcare infrastructure and rising healthcare expenditure in countries across the region have facilitated greater access to advanced wound care products, including active infection dressings, which offer benefits such as faster healing and reduced risk of infection. For instance, medical care costs in the Asia Pacific rose from 7.2% in 2022 to a high of 9.9% in 2023, indicated by the WTW Global Medical Trends Survey, with expectations for the insurer-reported cost trend to plateau at 9.9% in 2024, reflecting stability impacted by regional market variations, where some areas experience minimal changes while others show slight fluctuations in costs from 2023 to 2024.

Application Insights

The chronic wounds segment accounted for the largest revenue share in 2024. The application is segmented into chronic wounds and acute wounds. The chronic wounds segment is further segmented into diabetic foot ulcers, pressure ulcers, venous leg ulcers, and other chronic wounds. This is attributable to technological advancements, encompassing a range of solutions, such as advanced injury dressings, negative pressure wound therapy systems, products, and topical oxygen therapy devices, among others. These technologies offer improved efficacy, enhanced infection healing outcomes, and greater patient comfort than traditional trauma care methods.

In addition, advancements in telemedicine and remote monitoring technologies enable healthcare providers to deliver timely interventions and personalized care to patients with infections, further driving regional market growth. For instance, in November 2023, in South Korea, the NATROX O₂ topical oxygen therapy device, engineered by Inotec AMD-a spinout from Cambridge University-was launched. The device received approval from the Korean Ministry of Food & Drug Safety (MFDS) for shipment and sale within the country. Kove, serving as its distribution partner in South Korea, was expected to oversee its market introduction. Smaller in size than an iPhone, the device employs oxygen to promote infection healing by delivering continuous topical oxygen therapy (cTOT), offering a non-invasive and comfortable solution primarily designed to aid in healing chronic wounds.

The acute wounds segment is expected to grow at the fastest CAGR over the forecast period. It is further segmented into surgical and traumatic wounds and burns. The integration of artificial intelligence (AI) is a significant driving force behind the growth of the segment. AI-powered telemedicine platforms facilitate remote injury monitoring and consultation, improving access to specialized trauma care expertise, particularly in remote or underserved areas.

The integration of AI enhances clinical decision-making and patient outcomes and drives efficiency and cost-effectiveness in infection management across the region. For instance, in June 2023, Singaporean researchers created a wearable infection health monitoring patch called PETAL, which utilizes AI to detect deteriorating injury conditions and alert medical staff for timely intervention. This innovative wearable technology, developed collaboratively by scientists from the National University of Singapore (NUS) and the Agency for Science, Technology, and Research (A*STAR), aims to enhance burns care management.

End-use Insights

The hospitals segment held the largest market share in terms of revenue in 2024. This is attributable to the higher incidence of chronic diseases such as diabetes and cardiovascular conditions. As older individuals are more prone to injuries, hospitals experience a surge in patients requiring advanced wound care, leading to increased adoption of advanced wound care products and treatments. According to the Agency for Science, Technology, and Research (A*STAR), chronic infections afflict approximately 2-6% of populations in developed nations, constituting a substantial economic burden on healthcare systems.

In Australia, they account for 2% of the total national health expenditure, while in Wales, they represent 5.5% of NHS spending. The management of injuries incurs significant costs, encompassing expenses related to frequent consultations and dressing changes by healthcare providers. This burden is anticipated to escalate with demographic shifts, including an aging population and a rising prevalence of conditions such as diabetes and obesity in Singapore. As such, there is a pressing need for effective strategies to address the growing impact of trauma on healthcare resources and patient well-being.

The home care segment is projected to grow at the fastest CAGR over the forecast period owing to the increasing preference for home-based care among the aging population, rising healthcare costs, and advancements in wound care technologies that enable effective management of wounds in home settings. Furthermore, government initiatives promoting home healthcare and the growing awareness about the benefits of early wound care intervention are further accelerating the growth of this segment.

Country Insights

The advanced wound care market in Asia Pacific is expected to grow significantly, owing to the region's aging population, coupled with rising rates of injuries, burns, and surgeries, is creating a substantial demand for advanced wound care solutions. Furthermore, the increasing prevalence of chronic diseases like diabetes, cancer, and autoimmune disorders is contributing to a higher incidence of chronic wounds, further fueling market growth.

China Advanced Wound Care Market Trends

The China advanced wound care market had a revenue share of 20.89% in 2024. The country's growth can be attributed to its large aging population requiring advanced treatments and its rapid adoption of innovative wound care technologies, positioning it as a key player in the region’s healthcare sector. Moreover, major players are expanding their market presence by enhancing their product portfolio and widening distribution channels nationwide.

In addition, collaborations & partnerships with healthcare providers and hospitals are helping key players strengthen their market position. For instance, in April 2023, Gunze and Essex Bio-Technology Ltd. entered into an agency contract for PELNAC absorbable dressing, an invention by Gunze. As per the agreement's regulations, Essex Medipharma was recognized as PELNAC's sole agent in Mainland China for five years, from 2023 to 2027. Such initiatives are expected to boost market growth over the forecast period.

India Advanced Wound Care Market Trends

The India advanced wound care market is expected to witness the fastest CAGR during the forecast period. Several factors, including the increasing prevalence of chronic disorders and rising medical tourism, are driving market growth in this nation. The demand for advanced wound care products, such as foam dressings, alginate dressings, and wound cleansers, is increasing due to economic development, urbanization, and rising healthcare awareness, resulting in a rise in healthcare expenditure in the country. Continuous advancements in technology in the manufacture of advanced wound care products, compositions, and delivery methods are expected to propel the market growth in the coming years.

Key Asia Pacific Advanced Wound Care Company Insights

Some of the key players operating in the Asia Pacific advanced wound care industry include 3M, Smith & Nephew, Baxter, and Cardinal Health.

• Smith & Nephew is a medical technology firm specializing in developing, manufacturing, and marketing medical devices for orthopedic reconstruction, trauma, sports medicine, ENT, and advanced wound management. Their product range includes knee and hip implants, robotics-assisted technologies, trauma-related products for fracture stabilization, soft tissue repair instruments, and wound care products catering to surgeons, nurses, physicians, and healthcare purchasers in hospitals and insurance networks

• 3M manufactures and supplies industrial products and solutions across diverse sectors. Their product portfolio encompasses display systems, advanced materials, office supplies, home improvement, personal safety equipment, roofing materials, and more. In addition, 3M provides solutions in medical, oral care, consumer health, food safety, and health information systems, catering to various industries, including automotive, electronics, healthcare, safety, energy, and consumer goods

• ConvaTec Inc. provides diverse medical products and technologies, catering to various healthcare needs, including wound care, continence management, and infusion therapy, servicing hospitals, home care agencies, and retail distributors globally. Strategic investments by the firm are showcased below:

• Integra LifeSciences Corporation is a medical technology firm specializing in engineered collagen-based products, including surgical instruments, wound care, orthopedic hardware, implants, dermal regeneration products, and neurosurgery devices. Its solutions cater to orthopedic extremity surgery, neurosurgery, reconstructive, and general surgery, serving various healthcare settings such as hospitals, outpatient centers, and medical practices

• Mölnlycke Health Care AB, ConvaTec Inc., and Integra LifeSciences Corporation are some of the other market participants in the Asia Pacific market. Some of the insights from Mölnlycke Health Care AB:

Thus, due to such market activities by key companies, the demand for advanced wound care products among key customers will increase over the forecast period.

Recent Developments

• In July 2023, Smith & Nephew PLC introduced the REGENETEN Bioinductive Implant, accessible in India. The REGENETEN implant, a novel solution for rotator cuff surgeries, has been utilized in over 100,000 procedures.

• In April 2023, 3M announced the U.S. FDA approval for 3M Veraflo Therapy dressings intended for hydromechanical removal of nonviable tissue.

• In April 2023, Convatec Group PLC acquired 30 Technology Limited’s anti-infective nitric oxide technology platform, which includes new product assets and R&D. In addition to enhanced wound care, Convatec plans to explore the technical platform for use in other businesses.

Asia Pacific Advanced Wound Care Market Report Scope

Asia Pacific Advanced Wound Care Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the Asia Pacific advanced wound care market report based on product, application, end-use, and country:

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Moist

    • Foam Dressings

      • Adhesive

      • Non-adhesive Foam Dressings

    • Superabsorbent Dressings

    • Film Dressings

    • Hydrocolloid Dressings

    • Alginate Dressings

    • Hydrogel Dressings

    • Collagen Dressings

    • Charcoals Dressings

    • Wound Contact Layers

    • Greasy Gauzes

    • Other Advanced Dressings

  • Antimicrobial

    • Silver Dressings

    • Non-silver Dressings

      • Honey

      • Iodine

      • Chitosan

      • PHMB

      • Others

  • Active

    • Biomaterials

    • Skin-substitute

    • Growth factors

  • Wound Cleanser Products

    • Wetting Agents

    • Antiseptic

    • Moisturizers

    • Pulsed Lavage Systems

      • Disposable

      • Reusable

      • Semi Disposable         

    • Others

  • Compression Bandages

    • Long-Stretch Elastic Bandages

    • Short-Stretch Bandages

    • Multi-layer Bandages

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Chronic Wounds

    • Diabetic Foot Ulcers

    • Pressure Ulcers

      • Stage 1

      • Stage 2

      • Stage 3

      • Stage 4

      • Deep Tissue Injury

    • Venous Leg Ulcers

    • Other Chronic Wounds

  • Acute Wounds

    • Surgical & Traumatic Wounds

    • Burns

      • 1st Degree Burns

      • 2nd Degree Burns

      • 3rd Degree Burns

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Outpatient Facilities

  • Home Care

  • Others

• Country Outlook (Revenue, USD Million, 2018 - 2030)

  • China

  • India

  • Australia

  • Singapore

  • Vietnam

  • Thailand

  • Indonesia

  • South Korea

  • Hong Kong

  • Malaysia